Urologix, Inc. (
Q4 FY 2011 Earnings Call (Quarter Ended June 30, 2011)
August 23, 2011 5:00 p.m. ET
Stryker Warren, Jr. – CEO
Brian Smrdel – CFO
Ernie Andberg – Feltl & Co.
Good day, ladies and gentlemen, and welcome to the Urologix Incorporated Fiscal Year 2011 and Fourth Quarter Conference Call. My name is Melanie and I'll be your coordinator for today.
At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of the conference. As a reminder, this conference is being recorded for replay purposes.
Certain information discussed during this conference call, including answers to your questions, may contain forward-looking statements that are made pursuant to the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those stated or implied in any forward-looking statements due to risks and uncertainties. A detailed discussion of risks and uncertainties may be found in Urologix's recent annual report on Form 10-K for the year ended June 30, 2010 and other documents filed with the Securities and Exchange Commission. Urologix disclaims any obligation to update any forward-looking statements made during the course of this call.
At this time, I would turn the call over to Mr. Stryker Warren, Jr., Chief Executive Officer. Please proceed, sir.
Stryker Warren, Jr.
Good afternoon. I welcome you to this earnings call to discuss the company's results for the fourth quarter and fiscal year 2011. With me are Brian Smrdel, the company's Chief Financial Officer, and Greg Fluet, the Executive Vice President and Chief Operating Officer of Urologix. We're pleased you've joined us.